Renal Tumors with Clear/Light-Staining Cytoplasm | ||||||
Antibody | Clear Cell RCC | Chromophobe RCC | MITF/TFE Family Translocation-associated Carcinoma | Clear Cell Papillary RCC | Epithelioid Angiomyolipoma | |
CK7 | − | + (diffuse, occasionally patchy) | − | + (diffuse, almost 100% tumor cells) | − | |
CD10 | + (membranous) | −/(rarely +) | + | (but often – in TFEB carcinoma) | − | − |
Vimentin | + | − (rarely +) | −/+ | + | − | |
Ksp-cadherin | − | + | − | ND | − | |
CD117 | − | + (diffuse, often peripheral membranous accentuation) | − | ND | − | |
AMACR | − (rarely focal +) | − | + (usually) | − | − | |
EMA/MUC1 | + | + | − (rarely focal +) | + | − | |
PAN-CK(AE1/AE3) | + | + | − (rarely focal +) | + | − | |
CAIX | + (diffuse membranous) | − (+ perinecrotic areas) | − (+ in some cases) | + (diffuse membranous) | − | |
TFE3/TFEB | − | − | + | − | − | |
Parvalbumin | − | + | − | − | − | |
Melan-A(MART-1) | − | − | + in TFEB carcinoma, rarely + in TFE3 | − | + | |
HMB-45 | − | − | + in TFEB carcinoma, rarely + in TFE3 | − | + | |
MiTF | − | − | + in TFEB carcinoma, rarely + in TFE3 | − | + | |
Actin-sm | − | − | − | − | +/− |
Renal Tumors with Papillary or Tubulopapillary Architecture | |||||
Antibody | Papillary RCC | Collecting Duct Carcinoma | Metanephric Adenoma | Mucinous Tubular and Spindle Cell Carcinoma | Clear Cell Papillary RCC |
CK7 | + | + | − (may be + in branching tubules or papillary structures) | + | + |
CD10 | + (often luminal pattern) | − | − | −/+ (focal) | − |
RCC | + | − | − | V | −/+ |
AMACR | + | − | −/+ | + | − |
EMA/MUC1 | + | + | − (may be + in branching tubules or papillary structures) | + | + |
WT1 | − | − | + | − | − |
HMCK(34βE12) | − | +/− | − | −/+ | + |
CD57 | − | ND | + | − | ND |
INI1 | + | + (lost in renal medullary carcinoma) | + | + | + |
Ulex-1 | − | + | − | − | ND |
CAIX | − (+ perinecrotic areas and papillary tips) | −/+(perinecrotic area) | ND | ND | + |
(V = Variable, ND = No Data) |
Renal Tumors with Granular/Eosinophilic Cytoplasm | |||||
Antibody | Clear Cell RCC, Eosinophilic | Chromophobe RCC, Eosinophilic | Oncocytoma | MiTF/TFE Family Translocation-associated Carcinoma | Epithelioid Angiomyolipoma |
Vimentin | +/− | − (rarely +) | − | −/+ | + |
CD117 | − | + | + | − | − |
Pax-2 | + | − (rarely +) | + | V | − |
RCC | + | −/+ | −/+ | + | − |
CK7 | − | +/− | − | − | − |
CD10 | + | −/+ | + | + in TFE3 carcinoma, often (−) in TFEB | − |
Ksp-cadherin | − | + | + | V | − |
Parvalbumin | − | + | + | ND | − |
EpCAM/BER-EP4 | V | + | − (occasionally focal or patchy +) | V | − |
TFE3/TFEB | − | − | − | + | − |
Melan-A(MART-1) | − | − | − | + in TFEB carcinoma, rarely + in TFE3 | + |
HMB-45 | − | − | − | + in TFEB carcinoma, rarely + in TFE3 | + |
MiTF | − | − | − | + in TFEB carcinoma, rarely + in TFE3 | + |
Actin-sm | − | − | − | − | +/− |
HMCK(34βE12) | − | − (rarely focal +) | − | − (occasionally focal +) | − |
EMA/MUC1 | + | + (occasionally only focal +) | + (occasionally only focal +) | − (occasionally focal +) | − |
CAIX | + | − | − | − (+ in some cases) | − |